MedTrace Logo

A Web-Based Dyadic Intervention for Colorectal Cancer

NCT05663203 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-12-19

No results posted yet for this study

Summary

This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.

Conditions

  • Colorectal Carcinoma

Interventions

OTHER

Internet-Based Intervention

Attend CRCWeb intervention

OTHER

Interview

Complete interview

OTHER

Survey Administration

Complete survey

OTHER

Electronic Health Record Review

Medical records are reviewed

Sponsors & Collaborators

  • Oncology Nursing Society

    collaborator OTHER

  • Emory University

    lead OTHER

Principal Investigators

  • Yufen Lin, PhD, RN · Emory University Hospital/Winship Cancer Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2026-10-01
Completion
2027-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05663203 on ClinicalTrials.gov